FDA 483 - Frontage Clinical Services, Inc. - May 20, 2014

An FDA inspection of Frontage Clinical Services, Inc. in Hackensack, NJ, a bioavailability/bioequivalency clinical investigator, revealed one significant observation. The firm failed to retain reserve samples of test articles used in a bioavailability study. This indicates a lapse in proper sample retention procedures for clinical research.